Age and Refraction in Predicting Myopia Progression in COVID-19
- Conditions
- Refraction ErrorMyopia
- Registration Number
- NCT05305274
- Lead Sponsor
- Tianjin Eye Hospital
- Brief Summary
To determine the longitudinal changes of age and refraction in predicting myopia progression with risk under the coronavirus disease 2019 (COVID-19) pandemic in a 3-year follow-up of a Chinese cohort.
- Detailed Description
This was part of the large-scale Tianjin Eye Study, a population-based cohort study that longitudinally investigates the relationship between the age, refraction, and development of childhood RE in Tianjin, China.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 34400
- no concurrent eye disease;
- age 6-15 years.
- significant systemic illnesses
- ocular conditions that could affect the corneal curvature, including congenital corneal diseases,
- pterygium, keratoconus, other corneal degeneration or dystrophy conditions,
- media opacity, uveitis, glaucoma
- a history of intraocular surgery, refractive surgery,
- neurologic or retinal diseases, current corneal refractive therapy (ortho-K),
- low-dose atropine therapy for myopia control
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method changes of sphere change from baseline at 36 months changes of sphere
changes of spherical equivalent change from baseline at 36 months changes of spherical equivalent
changes and distribution of visual acuity change from baseline at 36 months changes and distribution of visual acuity
changes of cylinder change from baseline at 36 months changes of cylinder
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Tianjin Eye Hospital
🇨🇳Tianjin, China
Tianjin Eye Hospital🇨🇳Tianjin, China